相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evidence that opioids may have toll-like receptor 4 and MD-2 effects
Mark R. Hutchinson et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis
Mark Tidswell et al.
CRITICAL CARE MEDICINE (2010)
Statins for the Prevention and Treatment of Infections A Systematic Review and Meta-analysis
Imad M. Tleyjeh et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation
Matthijs Kox et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model
K. Takashima et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
THE NOVEL SELECTIVE TOLL-LIKE RECEPTOR 4 SIGNAL TRANSDUCTION INHIBITOR TAK-242 PREVENTS ENDOTOXAEMIA IN CONSCIOUS GUINEA-PIGS
Masamune Kuno et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
Critical Role for Asparagine Endopeptidase in Endocytic Toll-like Receptor Signaling in Dendritic Cells
Fernando E. Sepulveda et al.
IMMUNITY (2009)
Lipopolysaccharide-Trap-Fc, a Multifunctional Agent To Battle Gram-Negative Bacteria
Philipp Gross et al.
INFECTION AND IMMUNITY (2009)
Effects of Lansoprazole on the Lipopolysaccharide-Stimulated Toll-Like Receptor 4 Signal Transduction Systems: A Study Using the 293hTLR4/MD2-CD14 Cells
Tadashi Ohara et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2009)
Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis
Leo Jeng et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like receptor 4
Thierry Roger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Signal-transducing mechanisms of ketamine-caused inhibition of interleukin-1β gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells
Ta-Liang Chen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2009)
Inhibition of toll-like receptor-4, nuclear factor-κb and mitogen-activated protein kinase by lignocaine may involve voltage-sensitive sodium channels
Ping-Ying Lee et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain
Tomohiro Kawamoto et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers
Daniel P. Rossignol et al.
INNATE IMMUNITY (2008)
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure
Gabor Foldes et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9
Boyoun Park et al.
NATURE IMMUNOLOGY (2008)
Statins inhibit toll-like receptor 4-mediated lipopolysaccharide signaling and cytokine expression
Conrad P. Hodgkinson et al.
PHARMACOGENETICS AND GENOMICS (2008)
TLR signaling pathway in patients with sepsis
Reinaldo Salomao et al.
SHOCK (2008)
Opioid-induced immunosuppression
Paola Sacerdote
Current Opinion in Supportive and Palliative Care (2008)
Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury
Hideo Yasuda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Role of toll-like receptors in the development of sepsis
Hironori Tsujimoto et al.
SHOCK (2008)
Lidocaine attenuates lipopolysaccharide-induced acute lung injury through inhibiting NF-kappa B activation
Guang Feng et al.
PHARMACOLOGY (2008)
Role of Toll-like receptor responses for sepsis pathogenesis
Heike Weighardt et al.
IMMUNOBIOLOGY (2007)
Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model
Takukyu Sha et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Antagonism of lipopolysaccharide-induced blood pressure attenuation and vascular contractility
S. Ehrentraut et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist eritoran
Ho Min Kim et al.
CELL (2007)
Effects of ketamine on levels of cytokines, NF-κB and TLRs in rat intestine during CLP-induced sepsis
Min Yu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
Effects of ketamine on pulmonary TLR4 expression and NF-κ-B activation during endotoxemia in rats
M. Yu et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2007)
The innate immunity of the central nervous system in chronic pain: The role of Toll-like receptors
L.-H. Guo et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
A Phase II, double-blind, placebo-controlled, ascending-dose study of eritoran (E5564), a lipid a antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass
Elliott Bennett-Guerrero et al.
ANESTHESIA AND ANALGESIA (2007)
Nicotine exposure alters in vivo human responses to endotoxin
X. Wittebole et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Effects of ketamine on pulmonary inflammatory responses and survival in rats exposed to polymicrobial sepsis
Min Yu et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2007)
Siravastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo
Alexander Niessner et al.
ATHEROSCLEROSIS (2006)
Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors
O. Handa et al.
INFLAMMATION RESEARCH (2006)
E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes
E. Czeslick et al.
INFLAMMATION RESEARCH (2006)
Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-κB phosphorylation and nuclear factor-κB transcriptional activity through nicotinic acetylcholine receptor α7
H. Yoshikawa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Stimulation of α7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes
Ryosuke Hamano et al.
SHOCK (2006)
Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury
Akira Shimamoto et al.
CIRCULATION (2006)
Lidocaine inhibition of inducible nitric oxide synthase and cationic amino acid transporter-2 transcription in activated murine macrophages may involve voltage-sensitive Na+ channel
Ya-Hsien Huang et al.
ANESTHESIA AND ANALGESIA (2006)
A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-chloro-4-fluorophenyl) sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling
M Ii et al.
MOLECULAR PHARMACOLOGY (2006)
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response
PT Liu et al.
SCIENCE (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Sepsis in European intensive care units: Results of the SOAP study
JL Vincent et al.
CRITICAL CARE MEDICINE (2006)
Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns
K Sadeghi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Toll-like receptor 4, nitric oxide, and myocardial depression in endotoxemia
G Baumgarten et al.
SHOCK (2006)
1,25-Dihydroxyvitamin D-3 inhibits lipopolysaccharide-induced immune activation in human endothelial cells
O Equils et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Inhibition of TLR-4/MD-2 signaling by RP105/MD-1
S Divanovic et al.
JOURNAL OF ENDOTOXIN RESEARCH (2005)
Discovery of novel and potent small-molecule inhibitors of NO and cytokine production as antisepsis agents: Synthesis and biological activity of alkyl 6-(N-substituted sulfamoyl)cyclohex-1-ene-1-carboxylate
M Yamada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
WJ de Jonge et al.
NATURE IMMUNOLOGY (2005)
Expression of tumour necrosis factor receptor and Toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating
X Wittebole et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes
H Methe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105
S Divanovic et al.
NATURE IMMUNOLOGY (2005)
Toll-like receptors in innate immunity
K Takeda et al.
INTERNATIONAL IMMUNOLOGY (2005)
Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release
H Zhou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
Cathelicidins, multifunctional peptides of the innate immunity
M Zanetti
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Increased expression of toll-like receptor-2 and-4 on leukocytes from patients with sepsis
L Härter et al.
SHOCK (2004)
Inhibition of endotoxin response by synthetic TLR4 antagonists
LD Hawkins et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events
SM Boekholdt et al.
CIRCULATION (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Inhibition of endotoxin response by E5564, a novel toll-like receptor 4-directed endotoxin antagonist
M Mullarkey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Statin effects on cholesterol micro-domains in brain plasma membranes
C Kirsch et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia
M Lynn et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
H Wang et al.
NATURE (2003)
Broad expression of Toll-like receptors in the human central nervous system
M Bsibsi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3
OE Sorensen et al.
BLOOD (2001)
Cutting edge: Naturally occurring soluble form of mouse toll-like receptor 4 inhibits lipopolysaccharide signaling
K Iwami et al.
JOURNAL OF IMMUNOLOGY (2000)
A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia
E Bunnell et al.
CRITICAL CARE MEDICINE (2000)
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
LV Borovikova et al.
NATURE (2000)
Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins
JR Rose et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
